InSightec Ltd - Product Pipeline Analysis, 2023 Update

Summary


InSightec Ltd (InSightec), is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its services include commercial development advisory, free professional services, free platform upgrade, onsite support, parts warranty, periodic maintenance, business support, customer services, remote technical support and software upgrades. InSightec’s products are used by physicians in medical facilities in the treatment of tumor. It operates in China, Israel, Japan and the UK. InSightec is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InSightec Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


InSightec Ltd Company Overview
InSightec Ltd Company Snapshot
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
InSightec Ltd – Pipeline Analysis Overview
InSightec Ltd - Key Facts
InSightec Ltd - Major Products and Services
InSightec Ltd Pipeline Products by Development Stage
InSightec Ltd Ongoing Clinical Trials by Trial Status
InSightec Ltd Pipeline Products Overview
ExAblate - Brain Cancer
ExAblate - Brain Cancer Product Overview
ExAblate - Brain Cancer Clinical Trial
ExAblate - Liver Cancer
ExAblate - Liver Cancer Product Overview
ExAblate - Metastatic Breast Cancer
ExAblate - Metastatic Breast Cancer Product Overview
Exablate Neuro - Alzheimer’s Disease
Exablate Neuro - Alzheimer’s Disease Product Overview
Exablate Neuro - Alzheimer’s Disease Clinical Trial
Exablate Neuro System - NSCLC
Exablate Neuro System - NSCLC Product Overview
InSightec Ltd - Key Competitors
InSightec Ltd - Key Employees
InSightec Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InSightec Ltd, Recent Developments
Mar 04, 2024: Insightec’s Groundbreaking Transcranial Mr-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Mar 04, 2024: Insightec’s MRgFUS secures reimbursement boost in Germany
Jan 29, 2024: Insightec Announces Exablate Prime -The Next Generation of Mr-Guided Focused Ultrasound
Jan 29, 2024: Insightec Mr-Guided Focused Ultrasound Technology Recommended for National Coverage for Dutch Patients Living With Essential Tremor
Jan 24, 2024: US Military Members Now Eligible for Focused Ultrasound Treatment Reimbursement for Essential Tremor
Jan 04, 2024: Potential Breakthrough for Alzheimer’s Treatment: Focused Ultrasound Combined With Monoclonal Antibodies May Slow Disease Progression
Nov 14, 2023: InSightec Receives Additional 510(K) Clearance For Exablate Prostate System
Nov 02, 2023: Insightec Announces New Category I CPT Code from AMA for Neuro Procedures Using MR-Guided Focused Ultrasound
Sep 22, 2023: Insightec Announces Positive Coverage Decision by Humana for Focused Ultrasound to Treat Essential Tremor
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: InSightec Ltd Pipeline Products by Equipment Type
Table 3: InSightec Ltd Pipeline Products by Indication
Table 4: InSightec Ltd, Key Facts
Table 5: InSightec Ltd, Major Products and Services
Table 6: InSightec Ltd Number of Pipeline Products by Development Stage
Table 7: InSightec Ltd Pipeline Products Summary by Development Stage
Table 8: InSightec Ltd Ongoing Clinical Trials by Trial Status
Table 9: InSightec Ltd Ongoing Clinical Trials Summary
Table 10: ExAblate - Brain Cancer - Product Status
Table 11: ExAblate - Brain Cancer - Product Description
Table 12: ExAblate - Brain Cancer - A Safety and Feasibility Study to Evaluate Blood Brain Barrier Disruption Using Exablate MR Guided Focused Ultrasound in Combination With Doxorubicin in Treating Pediatric Patients with Diffuse Intrinsic Pontine Gliomas (DIPG)
Table 13: ExAblate - Liver Cancer - Product Status
Table 14: ExAblate - Liver Cancer - Product Description
Table 15: ExAblate - Metastatic Breast Cancer - Product Status
Table 16: ExAblate - Metastatic Breast Cancer - Product Description
Table 17: Exablate Neuro - Alzheimer’s Disease - Product Status
Table 18: Exablate Neuro - Alzheimer’s Disease - Product Description
Table 19: Exablate Neuro - Alzheimer’s Disease - A Phase IIa Study to Evaluate the Safety and Efficacy of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-guided Focused Ultrasound in Patients with Alzheimer's Disease
Table 20: Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
Table 21: Exablate Neuro - Alzheimer’s Disease - Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Table 22: Exablate Neuro System - NSCLC - Product Status
Table 23: Exablate Neuro System - NSCLC - Product Description
Table 24: InSightec Ltd, Key Employees
Table 25: InSightec Ltd, Other Locations
Table 26: Glossary
List of Figures
Figure 1: InSightec Ltd Pipeline Products by Equipment Type
Figure 2: InSightec Ltd Pipeline Products by Development Stage
Figure 3: InSightec Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings